Condition: Aneurysm · Aneurysm, Ruptured · Sponsor: Galaxy Therapeutics INC
Prospective, international, single-arm, multicenter, registry study. Patients presenting with evidence of Wide Neck unruptured or ruptured intracranial aneurysm (≤ 20 mm in widest diameter) requiring treatment will be enrolled into the study and treated using the SEAL™ System.
This description comes directly from the study's public registry record.
Osama O Zaidat, MD, MS · 12627515899 · szaidat@galaxytherapeutics.com
Sergi López García · +34690926013 · sergi@gtseal.com
Always discuss trial participation with your own doctor first.
| Angiosur | Itagüi, Medellín, Colombia | Recruiting |
| Auckland City Hospital | Auckland, Auckland, New Zealand | Recruiting |
| Punjab Institute of Neuroscience (PINS) | Lahore, Lahore, Pakistan | Recruiting |
| Hospital Universitari Vall d'Hebron | Barcelona, Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05880680